What are the different drugs, new approaches, and latest developments being tested in clinical trials? Learn about cutting-edge research and gain insights from the scientists who are advancing new treatment options.
Should you have adjuvant chemotherapy–treatment after pancreatic cancer surgery? Dr. Marco Del Chiaro explains that the evidence says “yes.”
Dr. Rosalie Sears is working with Biological Dynamics to test a new early detection blood assay and platform for pancreatic cancer screening.
The 2023 AACR meeting focused on the latest research into KRAS, other immunotherapy approaches, and honored Dr. Elizabeth Jaffee.
Researchers are comparing effectiveness of chemotherapy before surgery (neoadjuvant) with chemotherapy after surgery (adjuvant).
Dr. Laura Wood and colleagues are developing an artificial intelligence (AI) platform to identify tumors as they are forming.
Dr. Anna Bergamaschi explains the new Avantect blood test for the early detection of pancreatic cancer in people with type 2 diabetes.